Label for a vial

- Genentech, Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a bottom front left perspective view of the first embodiment for a label for a vial, showing our new design;

FIG. 2 is a front view thereof;

FIG. 3 is a rear view thereof;

FIG. 4 is a bottom view thereof;

FIG. 5 is a top view thereof;

FIG. 6 is a right side view thereof; and

FIG. 7 is a left side view thereof.

FIG. 8 is a perspective view of the first embodiment in a curled position;

FIG. 9 is a rear view thereof;

FIG. 10 is a front view thereof;

FIG. 11 is a left side view thereof;

FIG. 12 is a right side view thereof;

FIG. 13 is a bottom view thereof; and

FIG. 14 is a top view thereof.

FIG. 15 is a perspective view of the first embodiment in an alternate position;

FIG. 16 is a rear view thereof;

FIG. 17 is a front view thereof;

FIG. 18 is a left side view thereof;

FIG. 19 is a right side view thereof;

FIG. 20 is a bottom view thereof; and

FIG. 21 is a top view thereof.

FIG. 22 is a bottom front left perspective view of the second embodiment for a label for a vial, showing our new design;

FIG. 23 is a front view thereof;

FIG. 24 is a rear view thereof;

FIG. 25 is a bottom view thereof;

FIG. 26 is a top view thereof;

FIG. 27 is a right side view thereof; and

FIG. 28 is a left side view thereof.

FIG. 29 is a perspective view of the second embodiment in a curled position;

FIG. 30 is a rear view thereof;

FIG. 31 is a front view thereof;

FIG. 32 is a left side view thereof;

FIG. 33 is a right side view thereof;

FIG. 34 is a bottom view thereof; and

FIG. 35 is a top view thereof.

FIG. 36 is a perspective view of the second embodiment in an alternate position;

FIG. 37 is a rear view thereof;

FIG. 38 is a front view thereof;

FIG. 39 is a left side view thereof;

FIG. 40 is a right side view thereof;

FIG. 41 is a bottom view thereof; and

FIG. 42 is a top view thereof.

FIG. 43 is a perspective view of the first embodiment in an environment of use;

FIG. 44 is a rear view thereof;

FIG. 45 is a front view thereof;

FIG. 46 is a left side view thereof;

FIG. 47 is a right side view thereof;

FIG. 48 is a bottom view thereof; and

FIG. 49 is a top view thereof.

FIG. 50 is a perspective view of the first embodiment in an alternate position in an environment of use;

FIG. 51 is a rear view thereof;

FIG. 52 is a front view thereof;

FIG. 53 is a left side view thereof;

FIG. 54 is a right side view thereof;

FIG. 55 is a bottom view thereof; and

FIG. 56 is a top view thereof.

FIG. 57 is a perspective view of the second embodiment in an environment of use;

FIG. 58 is a rear view thereof;

FIG. 59 is a front view thereof;

FIG. 60 is a left side view thereof;

FIG. 61 is a right side view thereof;

FIG. 62 is a bottom view thereof; and

FIG. 63 is a top view thereof.

FIG. 64 is a perspective view of the second embodiment in an alternate position in an environment of use;

FIG. 65 is a rear view thereof;

FIG. 66 is a front view thereof;

FIG. 67 is a left side view thereof;

FIG. 68 is a right side view thereof;

FIG. 69 is a bottom view thereof; and,

FIG. 70 is a top view thereof.

The dash-dash broken lines illustrate portions of the label for the vial or environment that form no part of the claimed design.

The dash-dash broken lines illustrate portions of the label for a vial or environment that form no part of the claimed design.

Claims

The ornamental design for a label for a vial, as shown and described.

Referenced Cited
U.S. Patent Documents
1987418 January 1935 Plishker
3212214 October 1965 Patterson
3273781 September 1966 Mills
4048737 September 20, 1977 McDermott
D275177 August 21, 1984 Villanueva
5135125 August 4, 1992 Andel et al.
5490658 February 13, 1996 Coward et al.
5732491 March 31, 1998 Burtch
5823503 October 20, 1998 Wasserman
6110553 August 29, 2000 Grosskopf et al.
D443894 June 19, 2001 Schwartz
6546656 April 15, 2003 Twentier
D596240 July 14, 2009 Muniz
D613451 April 6, 2010 Welsh
D676490 February 19, 2013 Bratter
D676572 February 19, 2013 Tarriff
D702765 April 15, 2014 Williams
D729313 May 12, 2015 Glass
D741955 October 27, 2015 Clark
D752682 March 29, 2016 Sato
D785710 May 2, 2017 Lin
D785711 May 2, 2017 Lin
D786976 May 16, 2017 Keating
D860322 September 17, 2019 Edwards
D888828 June 30, 2020 Dittrich
D892212 August 4, 2020 Sato
20020073587 June 20, 2002 Twentier
20040104274 June 3, 2004 Kotik
20070014958 January 18, 2007 Chaplin et al.
Foreign Patent Documents
102004046552 April 2006 DE
102012015557 February 2014 DE
2695824 February 2014 EP
D129022 June 2009 TW
D140218 April 2011 TW
Other references
  • Albumin (Human) 25% Solution AlbuRx ®25, CSL Behring, located at <http://www.fffenterprises.com/assets/downloads/pi-Albumin-PPF_ALBURX%2025_CSL%20Behring.pdf> last visited Jan. 7, 2021, 2 pages.
  • Alburx 25% 100ml CSL, prescribing details, located at <https://biosupply.fffenterprises.com/alburx-25-100ml-esl-5.html#> last visited Jan. 7, 2021, 3 pages.
  • Goldberg, C. (Dec. 18, 2017). “Mass General Hospital Raises Red Flag About National Shortage of IV Fluids,” CommonHealth, located at <https://www.wbur.org/commonhealth/2017/12/18/mass-general-hospital-iv-fluids> last visited Jan. 7, 2021, 7 pages.
  • NDC 44206-310 Alburx, Albumin (human) description, located at <https://ndclist.com/ndc/44206-310#description> last visited Jan. 7, 2021, 7 pages.
Patent History
Patent number: D931370
Type: Grant
Filed: Jan 27, 2020
Date of Patent: Sep 21, 2021
Assignee: Genentech, Inc. (South San Francisco, CA)
Inventors: Mahesh Khurana (San Bruno, CA), Dominique Daniel Schall (Lörrach), Kai Zheng (Foster City, CA), Erin Susan Araj (Pleasanton, CA)
Primary Examiner: Mary Ann Calabrese
Assistant Examiner: Catherine Ho
Application Number: 29/722,202